Toll-like receptor 4 activation in platelets from myocardial infarction patients

Area of Science:

• Cardiovascular Biology
• Immunology
• Platelet Physiology

Background:

• Platelet toll-like receptor 4 (TLR4) is overexpressed in myocardial infarction (MI) patients.
• The activation status and triggering factors of platelet TLR4 in MI remain unclear.

Purpose of the Study:

• To investigate platelet TLR4 activation in MI patients.
• To identify potential triggers, specifically lipopolysaccharides (LPS), for platelet TLR4 activation in MI.

Main Methods:

• Serum LPS levels and ex vivo platelet aggregation (PA) were measured in MI patients and controls.
• TLR4 inhibitor (TLR4i) effects on collagen-stimulated PA were assessed.
• Platelet TIR domain-containing adaptor protein (TIRAP) phosphorylation and TIRAP-MyD88 interaction were analyzed.
• In vitro experiments examined LPS-induced TIRAP phosphorylation and its effect on platelet response.

Main Results:

• MI patients exhibited significantly higher serum LPS levels compared to controls.
• TLR4 inhibition reduced collagen-induced PA in MI platelets.
• Increased TIRAP phosphorylation and TIRAP-MyD88 interaction were observed in platelets from MI patients.
• In vitro, LPS activated TIRAP and amplified platelet response to agonists, an effect blocked by TLR4i.

Conclusions:

• Platelet TLR4 is activated in patients with myocardial infarction.
• Circulating lipopolysaccharides (LPS) are suggested as a potential trigger for platelet TLR4 activation in MI.